Wedbush Reiterated an Outperform on Cerulean Pharma (CERU) Following 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Cerulean Pharma (CERU) Tops Q3 EPS by 2c
November 16, 2015 4:38 PM ESTCerulean Pharma (NASDAQ: CERU) reported Q3 EPS of ($0.39), $0.02 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Cerulean Pharma (CERU) click here.
... MoreTrading Radar for 11/16: Agilent (A), Dillard's (DDS), YOU On Demand (YOD), Noah Holdings (NOAH) Report
November 13, 2015 3:09 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
American Electric Technologies (Nasdaq: AETI) - consensus EPS $0.07
Argos Therapeutics (Nasdaq: ARGS) - consensus loss $0.92
Asure Software (Nasdaq: ASUR) - consensus EPS $0.08
BioLineRx (Nasdaq:... More
